Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Accounts Payables (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Accounts Payables readings, the most recent being $190467.0 for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 23.31% to $190467.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $190467.0, a 23.31% increase, with the full-year FY2025 number at $100343.0, down 39.5% from a year prior.
  • Accounts Payables reached $190467.0 in Q1 2026 per CBIH's latest filing, up from $159116.0 in the prior quarter.
  • The five-year high for Accounts Payables was $257527.0 in Q1 2024, with the low at $100343.0 in Q2 2025.
  • A 4-year average of $159665.0 and a median of $159116.0 in 2025 define the central range for Accounts Payables.
  • Year-over-year, Accounts Payables skyrocketed 49.02% in 2024 and then crashed 40.02% in 2025.
  • Year by year, Accounts Payables stood at $213521.0 in 2023, then decreased by 22.2% to $166119.0 in 2024, then decreased by 4.22% to $159116.0 in 2025, then rose by 19.7% to $190467.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Accounts Payables are $190467.0 (Q1 2026), $159116.0 (Q4 2025), and $101297.0 (Q3 2025).